3-Bromo-2-chloro-5-nitropyridine

Catalog No.: 
ACIXRO208
CAS No.: 
5470-17-7
Molecular Formula: 
C5H2BrClN2O2
Molecular Weight: 
237.44
3-Bromo-2-chloro-5-nitropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$66.00In stockInquiry
500g98%$329.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-2-chloro-5-nitropyridine
IUPAC Name3-bromo-2-chloro-5-nitropyridine
MDL No.MFCD00233989
Molecular FormulaC5H2BrClN2O2
Molecular Weight237.44
SMILESO=[N+](C1=CN=C(Cl)C(Br)=C1)[O-]
InChI KeyPTTQIUHVDDBART-UHFFFAOYSA-N
SynonymEN300-86226 | A7943 | 3-Bromo-2-chloro-5-nitropyridine, 97% | PS-5452 | SCHEMBL3491271 | 3-Bromo-2-chloro-5-nitropyridine | 3-Bromo-2-chloro-5-nitro-pyridine | Q-103371 | B4077 | AC-25189 | DTXSID70282513 | MFCD00233989 | NSC 26278 | AKOS000538774 | SCHEM
CAS No.5470-17-7
PubChem CID230889

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACIXRO208 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRGKM927 route compound structure diagram
    ACRGKM92715862-33-6In Stock
  4. Then
  5. ACIXRO208 route product structure diagram
    ACIXRO2085470-17-7In Stock
Inquiry

2. ACIXRO208 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOMCW435 route compound structure diagram
    ACOMCW4355418-51-9In Stock
  2. Then
  3. ACIXRO208 route product structure diagram
    ACIXRO2085470-17-7In Stock
Inquiry

3. ACIXRO208 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRGKM927 route compound structure diagram
    ACRGKM92715862-33-6In Stock
  2. Then
  3. ACIXRO208 route product structure diagram
    ACIXRO2085470-17-7In Stock
Inquiry

Comments (0)